Rafina's Subsidiary C-Pharm Ltd Revenues for First Quarter 2021 $1.7 Million

About this update from Rafina Innovations Inc.

Nicosia, Cyprus, May 25, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Rafina Innovations Inc. (OTC PINK: VICA), a Medical and Pharmaceutical development company, is pleased to announce C-Pharm's 1st Quarter -31 March, 2021- revenues for 2021 are $1.7 Million US dollars. Rafina's CEO stated, "Over a year into the pandemic, C-Pharm managed to increase its revenues from $700,000 within the first quarter of 2020 to $1.7 million in the first quarter of 2021, by acquiring new business strategies, expanding in new territories and creating new opportunities during difficult times. We have significantly increased our distribution and sale in pharmaceutical products throughout Europe. The next goal is to expand further into the Europe – Asia territories." C-Pharm's unique business model allows Rafina to introduce its other suite of products to existing C-Pharm customers and industries. This is a massive opportunity for Rafina Innovations, Inc. to expand its businesses and create a global hub for medical supplies in addition to PPE and other related products and companies.  About Rafina Innovations Inc. Rafina Innovations Inc. is a development capital investment opportunity in the high growth / high margin prosthetics, orthotics, rehabilitation, and diabetes markets. It benefits from a market leading footing from which to expand and seeks to invest in a synergistic business model of Rafina Innovations Clinics and new technology development, with an out-licensing model. The company has a strong pipeline of near-market to research-stage technologies, developed by a team that includes world-renowned experts in their field, each committed to the company on an on-going basis. The Rafina Innovations Clinics can be early adopters of the technologies and provide the springboard for further innovation, as well as opportunities for lower-cost clinical trials. This synergistic model will allow the company to sustain high margins and accelerate revenue growth as both the number of clinics and products grow. About C-Pharm Ltd C-PHARM is a leading distributor for medical supplies and equipment striving to supply the world with everything needed. High Standards, Affordable Packages, Private Agreements, top quality and support are some of the words that define us, as a Company. Safe Harbor Statement: Safe harbor from liability established by the ...

View stock analysis, news, and events for Rafina Innovations Inc.